Growth Metrics

Pacific Biosciences Of California (PACB) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.27%
Dec 31, 2025 6.41%
Sep 30, 2025 -441.99%
Jun 30, 2025 83.94%
Mar 31, 2025 12.01%
Dec 31, 2024 -395.64%
Sep 30, 2024 21.22%
Jun 30, 2024 82.23%
Mar 31, 2024 11.01%
Dec 31, 2023 -63.60%
Sep 30, 2023 53.49%
Jun 30, 2023 -134.34%
Mar 31, 2023 54.15%
Dec 31, 2022 -153.44%
Sep 30, 2022 66.11%
Jun 30, 2022 6.61%
Mar 31, 2022 7.82%
Jun 30, 2021 50.70%
Mar 31, 2021 -1,031.88%
Dec 31, 2020 60.47%
Sep 30, 2020 -73.85%
Jun 30, 2020 15.87%
Mar 31, 2020 -376.46%
Dec 31, 2019 39.18%
Sep 30, 2019 26.39%
Jun 30, 2019 19.34%
Mar 31, 2019 19.03%
Dec 31, 2018 11.57%
Sep 30, 2018 -82.30%
Jun 30, 2018 19.90%
Mar 31, 2018 -26.07%
Dec 31, 2017 25.12%
Sep 30, 2017 18.16%
Jun 30, 2017 -83.04%
Mar 31, 2017 22.13%
Dec 31, 2016 17.58%
Sep 30, 2016 14.77%
Jun 30, 2016 -11.95%
Mar 31, 2016 -11.26%
Dec 31, 2015 -39.66%
Sep 30, 2015 18.94%
Jun 30, 2015 8.18%
Mar 31, 2015 21.90%
Dec 31, 2014 -2.05%
Sep 30, 2014 5.45%
Jun 30, 2014 11.54%
Mar 31, 2014 -5.52%
Dec 31, 2013 11.35%
Sep 30, 2013 -18.67%
Jun 30, 2013 -101.68%
Mar 31, 2013 47.27%
Dec 31, 2012 1.39%
Sep 30, 2012 -15.93%
Jun 30, 2012 45.47%
Mar 31, 2012 9.07%
Dec 31, 2011 38.93%
Sep 30, 2011 -19.48%
Jun 30, 2011 -187.38%
Mar 31, 2011 74.25%
Dec 31, 2010 -423.96%
Sep 30, 2010 30.43%